Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis
Frontiers in Psychiatry · 28.05.2024 · 15
DOI: 10.3389/fpsyt.2024.1407529 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 28.05.2024. Verfasst von Yue Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Mental health center and laboratory of psychiatry, West China Hospital of Sichuan University, Chengdu, China. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Anti-inflammatory agents have emerged as a potential new therapy for major depressive disorder (MDD). In this meta-analysis, our aim was to evaluate the antidepressant effect of anti-inflammatory agents and compare their efficacy.
Methods
We conducted a comprehensive search across multiple databases, including PubMed, Embase, Web of Science, Cochrane Review, Cochrane Trial, and ClinicalTrials.gov, to identify eligible randomized clinical trials. The primary outcome measures of our meta-analysis were efficacy and acceptability, while the secondary outcome measures focused on remission rate and dropout rate due to adverse events. We used odds ratio (OR) and 95% confidence interval (95% CI) to present our results.
Results
A total of 48 studies were included in our analysis. In terms of efficacy, anti-inflammatory agents demonstrated a significant antidepressant effect compared to placebo (OR = 2.04, 95% CI: 1.41–2.97, p = 0.0002). Subgroup analyses revealed that anti-inflammatory agents also exhibited significant antidepressant effects in the adjunctive therapy subgroup (OR = 2.17, 95% CI: 1.39–3.37, p = 0.0006) and in MDD patients without treatment-resistant depression subgroup (OR = 2.33, 95% CI: 1.53–3.54, p < 0.0001). Based on the surface under the cumulative ranking curve (SUCRA) value of network meta-analysis, nonsteroidal anti-inflammatory drugs (NSAIDs) (SUCRA value = 81.6) demonstrated the highest acceptability among the included anti-inflammatory agents.
Conclusion
In summary, our meta-analysis demonstrates that anti-inflammatory agents have significant antidepressant effects and are well-accepted. Furthermore, adjunctive therapy with anti-inflammatory agents proved effective in treating MDD. Among the evaluated anti-inflammatory agents, NSAIDs exhibited the highest acceptability, although its efficacy is comparable to placebo. Systematic Review Registration https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=422004 ), identifier CRD42023422004.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mental health center and laboratory of psychiatry, West China Hospital of Sichuan University, Chengdu, China.
Zitieren
APA
Du, Y., Dou, Y., Wang, M., Wang, Y., Yan, Y., Fan, H., Fan, N., Yang, X., & Ma, X. (2024). Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1407529
Vancouver
Du Y, Dou Y, Wang M, Wang Y, Yan Y, Fan H, et al. Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis. Frontiers in Psychiatry. 2024;15. doi:10.3389/fpsyt.2024.1407529
BibTeX
@article{Du2024,
author = {Du, Yue and Dou, Yikai and Wang, Min and Wang, Yu and Yan, Yushun and Fan, Huanhuan and Fan, Ningdan and Yang, Xiao and Ma, Xiaohong},
title = {Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis},
journal = {Frontiers in Psychiatry},
year = {2024},
volume = {15},
doi = {10.3389/fpsyt.2024.1407529}
}
EUVIMED